AQR Capital Management
INO icon

AQR Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

AQR Capital Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,171
Closed -$108K – 3525
2025
Q2 		$108K Sell
53,171
-20,404
-28% -$39.1K ﹤0.01% 3162
2025
Q1 		$120K Buy
+73,575
New +$148K ﹤0.01% 2980
2023
Q4 		– Sell
-37,476
Closed -$175K – 2386
2023
Q3 		$175K Buy
+37,476
New +$207K ﹤0.01% 2160
2021
Q2 		– Sell
-3,030
Closed -$337K – 2260
2021
Q1 		$337K Sell
3,030
-3,946
-57% -$519K ﹤0.01% 1970
2020
Q4 		$741K Sell
6,976
-2,624
-27% -$349K ﹤0.01% 1633
2020
Q3 		$1.34M Buy
9,600
+4,248
+79% +$886K ﹤0.01% 1278
2020
Q2 		$1.73M Buy
+5,352
New +$859K ﹤0.01% 1221
2017
Q3 		– Sell
-1,526
Closed -$144K – 2262
2017
Q2 		$144K Sell
1,526
-839
-35% -$71.8K ﹤0.01% 2158
2017
Q1 		$188K Sell
2,365
-883
-27% -$70.4K ﹤0.01% 2119
2016
Q4 		$271K Sell
3,248
-1,960
-38% -$177K ﹤0.01% 2082
2016
Q3 		$582K Buy
+5,208
New +$575K ﹤0.01% 1897
2015
Q3 		– Sell
-898
Closed -$88K – 2211
2015
Q2 		$88K Hold
898
– – ﹤0.01% 2174
2015
Q1 		$88K Sell
898
-3,985
-82% -$386K ﹤0.01% 2089
2014
Q4 		$538K Sell
4,883
-942
-16% -$115K ﹤0.01% 1930
2014
Q3 		$689K Hold
5,825
– – ﹤0.01% 1809
2014
Q2 		$756K Hold
5,825
– – ﹤0.01% 1783
2014
Q1 		$931K Buy
5,825
+2,940
+102% +$422K ﹤0.01% 1737
2013
Q4 		$402K Buy
+2,885
New +$289K ﹤0.01% 2169

Other funds holding INO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management's INO Position: Q3 2025 in Review

AQR Capital Management sold out of Inovio Pharmaceuticals (INO) in Q3 2025, closing a stake of 53,171 shares — an estimated $108K sold.

AQR Capital Management first reported a position in INO in Q4 2013 and held it in 18 quarters. The position peaked at $1.73M in Q2 2020. 99 funds tracked by Wall St. Rank hold INO as of Q3 2025.

  • AQR Capital Management reported no remaining Inovio Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 53,171 Inovio Pharmaceuticals shares in Q3 2025, an estimated $108K.
  • AQR Capital Management first reported a position in Inovio Pharmaceuticals in Q4 2013 and held it in 18 quarters.
  • AQR Capital Management's Inovio Pharmaceuticals position peaked at $1.73M in Q2 2020.
  • 99 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.